Rtw Investments, LP has filed its 13F form on August 14, 2025 for Q2 2025 where it was disclosed a total value porftolio of $6.51 Billion distributed in 73 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Madrigal Pharmaceuticals, Inc. with a value of $603M, Natera, Inc. with a value of $438M, Ptc Therapeutics, Inc. with a value of $378M, Argenx Se with a value of $371M, and Protagonist Therapeutics, Inc with a value of $318M.

Examining the 13F form we can see an increase of $407M in the current position value, from $6.1B to 6.51B.

Rtw Investments, LP is based out at New York, NY

Below you can find more details about Rtw Investments, LP portfolio as well as his latest detailed transactions.

Portfolio value $6.51 Billion
Healthcare: $6.51 Billion

Stock Holdings Table

Stock Market Cap. Holding Value (Reported) # of Shares. Last Trade Trade History

Summary

  • Portfolio
  • No. of Stocks 73
  • Current Value $6.51 Billion
  • Prior Value $6.1 Billion
  • Filing
  • Period Q2 2025
  • Filing Date August 14, 2025
  • Form Type 13F-HR
  • Activity in Q2 2025
  • New Purchases 11 stocks
  • Additional Purchases 26 stocks
  • Sold out of 0 stocks
  • Reduced holdings in 7 stocks
Track This Portfolio

Track Rtw Investments, LP Portfolio

Follow Rtw Investments, LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rtw Investments, LP, based on Form 13F filings with the SEC.

News

Stay updated on Rtw Investments, LP with notifications on news.